SCHEMBL7987920

SCHEMBL7987920

NC(=O)c1c(NC(=O)c2ccccc2F)ncn1Cc1ccccc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 7/20 0.47
LMNA P02545 4/20 0.47
RXFP1 Q9HBX9 2/20 0.47
MAPT P10636 3/20 0.45
AURKA O14965 1/20 0.43
RPS6KB1 P23443 1/20 0.43
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
PDE4A P27815 3/20 0.41
PDE4B Q07343 3/20 0.41
PDE4C Q08493 3/20 0.41
PDE4D Q08499 3/20 0.41
PDE5A O76074 3/20 0.41
PDE1A P54750 2/20 0.41
PDE1B Q01064 2/20 0.41
PDE3B Q13370 2/20 0.41
PDE1C Q14123 2/20 0.41
PDE3A Q14432 2/20 0.41
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7984751 0.89 NTRK1 (0.46) TP53LMNARXFP1MAPTMEN1
SCHEMBL7991521 0.89 ADORA3 (0.47) TP53RXFP1MAPTAURKAMEN1
SCHEMBL7987851 0.87 LMNA (0.46) TP53LMNARXFP1MAPTMEN1
SCHEMBL7991269 0.85 TP53 (0.46) TP53LMNARXFP1MAPTMEN1
SCHEMBL7987938 0.84 KDM4E (0.44) TP53LMNARXFP1MAPTMEN1
SCHEMBL7974240 0.83 RAB9A (0.47) MAPTAURKAMEN1KMT2ATDP1
SCHEMBL7974172 0.83 HDAC3 (0.44) LMNAHSD17B13SMN1; SMN2ALDH1A1NPC1
SCHEMBL7985375 0.82 KDM4E (0.47) TP53RXFP1MAPTAURKATDP1
SCHEMBL7988763 0.82 NR1H4 (0.43) TP53LMNAMAPTTDP1SMN1; SMN2
SCHEMBL7987763 0.81 RAB9A (0.44) AURKAMEN1KMT2ATDP1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed